Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2017, Article ID 3925868, 6 pages
https://doi.org/10.1155/2017/3925868
Research Article

Molecular Study of Acinetobacter baumannii Isolates for Metallo-β-Lactamases and Extended-Spectrum-β-Lactamases Genes in Intensive Care Unit, Mansoura University Hospital, Egypt

1Medical Microbiology and Immunology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
2Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

Correspondence should be addressed to Nashwa M. Alkasaby; moc.oohay@3002ybsakawhsan

Received 25 December 2016; Revised 28 March 2017; Accepted 10 April 2017; Published 8 May 2017

Academic Editor: Todd R. Callaway

Copyright © 2017 Nashwa M. Alkasaby and Maysaa El Sayed Zaki. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Perez, A. M. Hujer, K. M. Hujer, B. K. Decker, P. N. Rather, and R. A. Bonomo, “Global challenge of multidrug-resistant Acinetobacter baumanni,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 10, pp. 3471–3484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Yeom, J.-H. Shin, J.-Y. Yang, J. Kim, and G.-S. Hwang, “1H NMR-based metabolite profiling of planktonic and biofilm cells in acinetobacter baumannii 1656-2,” PLoS ONE, vol. 8, no. 3, Article ID e57730, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Noori, A. Karimi, F. Fallah et al., “High prevalence of metallo-beta-lactamase producing Acinetobacter baumannii isolated from two hospitals of Tehran, Iran,” Archives of Pediatric Infectious Diseases, vol. 2, no. 3, Article ID e15439, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Karageorgopoulos, T. Kelesidis, I. Kelesidis, and M. E. Falagas, “Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 1, pp. 45–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Safari, M. Saidijam, A. Bahador, R. Jafari, and M. Y. Alikhani, “High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran,” Journal of Research in Health Sciences, vol. 13, no. 2, pp. 162–167, 2013. View at Google Scholar
  6. S.-C. Kuo, S.-C. Chang, H.-Y. Wang et al., “Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: Nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program,” BMC Infectious Diseases, vol. 12, article 200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Franklin, L. Liolios, and A. Y. Peleg, “Phenotypic detection of carbapenem-susceptible metallo-β-lactamase- producing gram-negative bacilli in the clinical laboratory,” Journal of Clinical Microbiology, vol. 44, no. 9, pp. 3139–3144, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. M. Cerqueira and A. Y. Peleg, “Insights into Acinetobacter baumannii pathogenicity,” IUBMB Life, vol. 63, no. 12, pp. 1055–1060, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. E. Falagas and D. E. Karageorgopoulos, “Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: need for international harmonization in terminology,” Clinical Infectious Diseases, vol. 46, no. 7, pp. 1121–1122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. L. L. Maragakis and T. M. Perl, “Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options,” Clinical Infectious Diseases, vol. 46, no. 8, pp. 1254–1263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Fallah, M. Noori, A. Hashemi et al., “Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM genes among Acinetobacter baumannii isolated from two hospitals of Tehran, Iran,” Scientifica, vol. 2014, 2014. View at Publisher · View at Google Scholar
  12. K. A. Sofy, A. E. Saafan, S. M. AbdelGhani, and M. A. Amin, “Phenotypic and genotypic characterization of different classes of β-lactamases amongst Acitobacter spp. Isolated from Egyptian hospitals.,” New Egyptian Journal of Microbiology, vol. 42, pp. 11–18, 2015. View at Google Scholar
  13. J. F. Turton, N. Woodford, J. Glover, S. Yarde, M. E. Kaufmann, and T. L. Pitt, “Identification of Acinetobacter baumannii by detection of the bla OXA-51-like carbapenemase gene intrinsic to this species,” Journal of Clinical Microbiology, vol. 44, no. 8, pp. 2974–2976, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-J. Monstein, Å. Östholm-Balkhed, M. V. Nilsson, M. Nilsson, K. Dornbusch, and L. E. Nilsson, “Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae,” APMIS, vol. 115, no. 12, pp. 1400–1408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Ellington, J. Kistler, D. M. Livermore, and N. Woodford, “Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 2, pp. 321–322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Clinical and Laboratory Standards Institute (CLSI), “Performance standards for antimicrobial susceptibility testing; twentythird informational supplement,” Tech. Rep. M100-S23, CLSI, Wayne, Pa, USA, 2013. View at Google Scholar
  17. D. Yong, K. Lee, J. H. Yum, H. B. Shin, G. M. Rossolini, and Y. Chong, “Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp.,” Journal of Clinical Microbiology, vol. 40, no. 10, pp. 3798–3801, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. K. S. Thomson, “Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues,” Journal of Clinical Microbiology, vol. 48, no. 4, pp. 1019–1025, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Woodford, M. J. Ellington, J. M. Coelho et al., “Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.,” International Journal of Antimicrobial Agents, vol. 27, no. 4, pp. 351–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Kulah, M. J. Mooij, F. Comert et al., “Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey,” International Journal of Antimicrobial Agents, vol. 36, no. 2, pp. 114–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Abdalhamid, H. Hassan, A. Itbaileh, and M. Shorman, “Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia,” The New Microbiologica, vol. 37, no. 1, pp. 65–73, 2014. View at Google Scholar · View at Scopus
  22. M. H. Al-Agamy, N. G. Khalaf, M. M. Tawfick, A. M. Shibl, and A. E. Kholy, “Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt,” International Journal of Infectious Diseases, vol. 22, pp. 49–54, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Rynga, M. Shariff, and M. Deb, “Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India,” Annals of Clinical Microbiology and Antimicrobials, vol. 14, no. 1, article no. 40, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. R. B. Patwardhan, P. K. Dhakephalkar, K. B. Niphadkar, and B. A. Chopade, “A study on nosocomial pathogens in ICU with special reference to mutiresistant Acinetobacter baumannii multiple plasmids,” Indian Journal of Medical Research, vol. 128, pp. 178–187, 2008. View at Google Scholar
  25. S. H. Ahmed, S. F. Abdelwahab, A. M. Hasanen, and D. S. Mohammed, “Multidrug resistant Egyptian isolates of Acinetobacter baumannii,” Journal of American Science, vol. 7, no. 1, pp. 1013–1019, 2011. View at Google Scholar
  26. M. Fouad, A. S. Attia, W. M. Tawakkol, and A. M. Hashem, “Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals,” International Journal of Infectious Diseases, vol. 17, no. 12, pp. e1252–e1254, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Fallah, A. Taherpour, M. H. Vala, and A. Hashemi, “Global spread of New Delhi mettallo-beta-lactamase-1 (NDM-1),” Archives of Clinical Infectious Diseases, vol. 6, no. 4, pp. 171–177, 2012. View at Google Scholar
  28. M. Safari, A. S. Mozaffari Nejad, A. Bahador, R. Jafari, and M. Y. Alikhani, “Prevalence of ESBL and MBL encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units (ICU),” Saudi Journal of Biological Sciences, vol. 22, no. 4, pp. 424–429, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Peymani, M. R. Nahaei, S. Farajnia et al., “High prevalence of metallo-b-lactamase-producing acinetobacter baumannii in a teaching hospital in Tabriz, Iran,” Japanese Journal of Infectious Diseases, vol. 64, pp. 69–71, 2011. View at Google Scholar
  30. P. Owlia, L. Azimi, A. Gholami, B. Asghari, and A. R. Lari, “ESBL-and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients,” Le Infezioni in Medicina, vol. 20, no. 3, pp. 182–187, 2012. View at Google Scholar
  31. P. Sacha, P. Wieczorek, D. Ojdana et al., “Susceptibility, phenotypes of resistance, and extended-spectrum beta-lactamases in Acinetobacter baumannii strains,” Folia Histochemica et Cytobiologica, vol. 50, no. 1, pp. 46–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. SM. El-Ageery, MA. Abo-Shadi, AA. Alghaithy, MA. Ahmad, NH. Alsharif, and SA. Alharbi, “Epidemiological investigation of nosocomial infection with multidrug-resistant Acinetobacter baumannii,” European Review for Medical and Pharmacological Sciences, vol. 16, pp. 1834–1839, 2012. View at Google Scholar
  33. N. Dai, Li. DZ, J. C. Chen et al., “Drug-resistant genes carried by Acinetobacter baumanii isolated from patients with lower respiratory tract infection,” Chinese Medical Journal, vol. 123, no. 18, pp. 2571–2575, 2010. View at Google Scholar
  34. S. M. Amudhan, U. Sekar, K. Arunagiri, and B. Sekar, “OXA betaβ-lactamase-mediated carbapenem resistance in Acinetobacter baumannii,” Indian Journal of Medical Microbiology, vol. 29, no. 3, pp. 269–274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. Rezaee, O. Pajand, M. R. Nahaei et al., “Prevalence of Ambler class A β-lactamases and ampC expression in cephalosporin-resistant isolates of Acinetobacter baumannii,” Diagnostic Microbiology and Infectious Disease, vol. 76, no. 3, pp. 330–334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. N. A. Al-Sweih, M. Al-Hubail, and V. O. Rotimi, “Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait,” Journal of Infection and Public Health, vol. 5, no. 1, pp. 102–108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Chen, S. Qlu, Y. Wang et al., “Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant acinetobacter baumannii isolates in China,” Clinical Infectious Diseases, vol. 52, no. 5, pp. 692–693, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Lee, W. G. Lee, Y. Uh, H. a. GY, J. Cho, and Y. Chong, “Korean Nationwide Surveillance of Antimicrobial Resistance Group. VIM-and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. Korean hospitals,” Emerging Infectious Diseases, vol. 7, pp. 868–871, 2003. View at Google Scholar
  39. M. Shanthi Amudhan, U. Sekar, A. Kamalanathan, and S. Balaraman, “blaIMP and blaVIM mediated carbapenem resistance in pseudomonas and acinetobacter species in India,” Journal of Infection in Developing Countries, vol. 6, no. 11, pp. 757–762, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Fattouh and A. N. El-din, “Emergence of carbapenem-resistant acinetobacter baumannii in the intensive care unit in Sohag University Hospital, Egypt,” International Journal of Current Microbiology and Applied Sciences, vol. 3, no. 4, pp. 732–744, 2014. View at Google Scholar
  41. M. N. Moghadam, M. Motamedifar, J. Sarvari, H. S. EbrahimSaraie, M. M. Same, and F. N. Moghadam, “Emergence of multidrug resistance and metallobetalactamase producing acinetobacter baumannii isolated from patients in Shiraz, Iran,” Annals of Medical and Health Sciences Research, vol. 6, no. 3, pp. 162–167, 2016. View at Google Scholar